Avvaa World Health Care Products Inc (AVVH)

[Scuba J]

Richmond, VA, February 24, 2012 — avVaa World Health Care Products Inc. (“avVaa” or the “Company”) (Pink Sheets: AVVH) wishes to update the shareholders on recent events.

The company wishes to announce that Jason Price has been appointed to the Board of Directors as President and Chief Operations Officer. Jason has over 20 years of diversified business experience in the Information Technology industry where he currently holds a Six Sigma Green Belt. He has worked behind the scenes with Ms. Brennan developing the new website and implementing the new distributor program. His initial priority will be to grow the new distributor program.

The new distributor program shows great potential to expand avVaa’s product reach through the addition of new distributors and customers around the world. The program provides multiple ways for distributors to earn an income through face-to-face interaction or website sales. Distributors can earn up to 40% commission through retail sales, referral bonuses for introducing new distributors, retirement bonuses, and profit sharing. Jason Price comments, "We are extremely excited to offer this opportunity to motivated individuals interested in getting in at the ground floor. Building distributorships creates exposure to a much broader market."

The company also wishes to announce that it has relocated its corporate headquarters from British Columbia, Canada to Richmond, Virginia in the United States. Richmond, Virginia was selected for its robust economy, pro-business climate and its quality workforce. In addition, Virginia continues to rank among America's leading states for business by CNBC and Forbes.com. This move will allow us to better support our new distributor program.

About avVaa World Health Care Products avVaa World Health Care Products is a global biotechnology company that specializes in effective, natural, therapeutic skin care products that improve quality of life and wellbeing for consumers. avVaa's patented European skin care formulas are scientifically registered, NHP-Compliant, and were developed to relieve and treat the symptoms of common skin ailments, including eczema, psoriasis and acne. avVaa is poised to manufacture and market its OTC Neuroskin® line of skin care products through mass food and drug channels in the United States and globally. The Company's secondary line of equine and pet care related products are already being distributed throughout all of Canada. For more information, visit: www.avvaa.com

Safe Harbor: This news release contains statements which may constitute "forward-looking statements" within the meaning of the Securities Act of 1933 and the Securities Exchange Act of 1934, as amended by the Private Securities Litigation Reform Act of 1995. Those statements include statements regarding the intent, belief or current expectations of avVaa World Health Care Products, and members of its management, as well as the assumptions on which such statements are based. Prospective investors are cautioned that any such forward-looking statements are not guarantees of future performance and involve risks and uncertainties, and that actual results may differ materially from those contemplated by such forward-looking statements. Important factors currently known to management that could cause actual results to differ materially from those in forward-statements include fluctuation of operating results, the ability to compete successfully and the ability to complete before-mentioned transactions. The Company undertakes no obligation to update or revise forward-looking statements to reflect changed assumptions, the occurrence of unanticipated events or changes to future operating results. Potential risks and uncertainties include, but are not limited to, the ability to procure, properly price, retain, and successfully complete projects, the availability of technical personnel, changes in technology, and competition.

http://avvaa.com/t/PressReleases